ruconest pharming group pharming healthcare

Pharming buys their business. An OIG investigation will show that pharming pays their doctors for over 95% of patients. Quid pro quo. Pharming managers require their ruconest account managers to set up speaker events. Ruconest costs up to $500k a year for treatment. All of their patient...